Nvidia
The company offers computer vision technology that enables humanoids and robots to perceive the world in 3D similar to how humans use their eyes and depth perception.
Also, Singapore has approved a lung cancer imaging AI platform.
The Polyphonic AI Fund for Surgery will invest in and provide mentorship to AI-enabled platforms aiming to advance surgical innovation.
The collaboration will center on advancing AI-powered image reconstruction and embedding real-time clinical decision support into portable MRI workflow.
The AI neural network will aid biomolecular research by predicting protein function, identifying novel molecules, assessing gene mutations and generating biological sequences.
J&J Medtech will use NVIDIA's technology to expand the use of AI in surgery centers in assisting with surgical decision-making and collaborating across operating rooms.
Also, AIRS Medical has proved the capability of its AI MRI reconstruction tool to denoise and improve the quality of 3D MR images.
This new tool builds on the company's previously released Clara Holoscan.
Third-party developers can use the platform to build their own products or update instruments.
The partners will use a new method of training AI known as transformer neural networks.